AVITA MEDICAL

Avita is a medical company that specializes in regenerative medicine, chronic wounds, and plastic surgery. It provides a novel approach to skin regeneration. Our products provide innovative treatment solutions derived from the regenerative properties of a patientโs own skin.
AVITA MEDICAL
Industry:
Biotechnology Health Care Medical Device
Founded:
1999-01-01
Address:
Valencia, California, United States
Country:
United States
Website Url:
http://www.avitamedical.com
Total Employee:
101+
Status:
Active
Contact:
1-833-462-8482
Email Addresses:
[email protected]
Total Funding:
248.36 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Amazon Font Awesome Global Site Tag
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
ITeos Therapeutics
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Nano Precision Medical
Nano Precision Medical develops novel miniaturized subdermal implants
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
ViaCyte
ViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes.
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Post-IPO Debt - Avita Medical
BioScience Managers Limited
BioScience Managers Limited investment in Post-IPO Equity - Avita Medical
Oceania Capital Partners
Oceania Capital Partners investment in Post-IPO Equity - Avita Medical
Key Employee Changes
Official Site Inspections
http://www.avitamedical.com Semrush global rank: 2.72 M Semrush visits lastest month: 6.44 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Avita Medical"
Avita Medical - Wikipedia
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marโฆSee details»
Avita Medical - Crunchbase Company Profile & Funding
Avita is a medical company that specializes in regenerative medicine, chronic โฆSee details»
AVITA Medical (ASX:AVH) Company Profile & Description
3 days ago Company profile for AVITA Medical, Inc. (ASX:AVH) with a description, list of executives, contact details and other key facts.See details»
Avita Medical Inc Company Profile - Overview - GlobalData
Avita Medical Inc (Avita Medical) is a commercial-stage regenerative medical device company. It develops products to meet the unmet medical needs of patients in conditions such as burns โฆSee details»
About - AVITA Medical, Inc.
AVITA Medical is a commercial-stage regenerative medicine company transforming the standard of care in wound care management and skin โฆSee details»
AVITA Medical, Inc. - Executive Bio, Top Executies, and Transitions ...
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.See details»
Leadership - AVITA Medical, Inc.
The AVITA Medical leadership team is comprised of experienced medical device experts with vast experience spanning diverse โฆSee details»
AVITA Medical Reports Second Quarter 2025 Financial Results, โฆ
4 days ago VALENCIA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering โฆSee details»
Investor Relations: Overview | AVITA Medical, Inc.
The Investor Relations website contains information about AVITA Medical, Inc.'s business for stockholders, potential investors, and financial analysts.See details»
AVITA Medical to Announce First Quarter 2025 Financial Results
VALENCIA, Calif., April 17, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound company delivering transformative solutions, โฆSee details»
Investor Relations - AVITA Medical, Inc.
AVITA Medical® is a regenerative medicine company leading the development and commercialization of devices and autologous cellular therapies for skin restoration. Our FDA โฆSee details»
AVITA Medical Reports Second Quarter 2025 Financial Results, โฆ
3 days ago AVITA Medical Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical InnovationSee details»
Investor Relations: AVITA Medical Reports First Quarter 2025 โฆ
VALENCIA, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative โฆSee details»
Investor Relations: AVITA Medical to Host Investor Webinar โฆ
1 day ago VALENCIA, Calif., Aug. 10, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering โฆSee details»
Compliance and Ethics - AVITA Medical, Inc.
AVITA Medical is committed to high standards of ethical behavior and compliance. View our code of business conduct and ethics, and compliance program and hotline.See details»
AVITA Medical Reports Second Quarter 2025 Financial Results, โฆ
4 days ago VALENCIA, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering โฆSee details»
Investor Relations: AVITA Medical to Announce Second Quarter โฆ
Jul 28, 2025 VALENCIA, Calif. and MELBOURNE, Australia, July 28, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic โฆSee details»
AVITA Medical Updates Expected Fourth Quarter and Full Year โฆ
Jan 7, 2025 For the quarter ended December 31, 2024, AVITA Medical now expects commercial revenue to be approximately $18.4 million, reflecting growth of around 30% over the same โฆSee details»
Investor Relations: AVITA Medical Reports Fourth Quarter and Full โฆ
Dec 19, 2024 VALENCIA, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering โฆSee details»
AVITA Medical Reports First Quarter Financial Results
VALENCIA, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class โฆSee details»